Zobrazeno 1 - 6
of 6
pro vyhledávání: '"perianal form"'
Autor:
O V Knyazev, A V Kagramanova, A A Lishchinskaya, N G Samsonova, N V Orlova, V A Rogozina, A I Parfenov
Publikováno v:
Терапевтический архив, Vol 90, Iss 6, Pp 74-80 (2018)
Aim. To assess the efficacy and tolerance of certolizumab pegol (CP) in patients with Crohn's disease (CD) treated in the Department of inflammatory bowel diseases of the A.S. Loginov Moscow Clinical Research Center and to determine the predictors of
Externí odkaz:
https://doaj.org/article/6b37c0902d3d446d94e59e9d5fa06822
Autor:
O V Knyazev, A V Kagramanova, I N Ruchkina, N A Fadeeva, A A Lishchinskaya, O N Boldyreva, E Yu Zhulina, P L Shcherbakov, N V Orlova, M V Kirova, A I Parfenov
Publikováno v:
Терапевтический архив, Vol 89, Iss 2, Pp 20-27 (2017)
Aim. To evaluate the efficacy and safety of adalimumab (ADA) in patients with Crohn’s disease (CD) treated at the Department of Inflammatory Bowel Diseases, Moscow Clinical Research and Practical Center, and to determine the predictors of a therapy
Externí odkaz:
https://doaj.org/article/0b5d77866b324af1bbbd51c41b9389ca
Autor:
A A Lishchinskaya, Oleg Knyazev, A V Kagramanova, A I Parfenov, V A Rogozina, N V Orlova, N.G. Samsonova
Publikováno v:
Терапевтический архив, Vol 90, Iss 6, Pp 74-80 (2018)
Aim. To assess the efficacy and tolerance of certolizumab pegol (CP) in patients with Crohn's disease (CD) treated in the Department of inflammatory bowel diseases of the A.S. Loginov Moscow Clinical Research Center and to determine the predictors of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32a1ecbd8476e6f5f73ed1206c53155c
https://doi.org/10.26442/terarkh201890674-80
https://doi.org/10.26442/terarkh201890674-80
Autor:
E.Yu. Zhulina Zhulina, P L Shcherbakov, Oleg Knyazev, O N Boldyreva, N A Fadeeva, M V Kirova, A I Parfenov, A V Kagramanova, I N Ruchkina, N V Orlova, A A Lishchinskaya
Publikováno v:
Терапевтический архив, Vol 89, Iss 2, Pp 20-27 (2017)
To evaluate the efficacy and safety of adalimumab (ADA) in patients with Crohn's disease (CD) treated at the Department of Inflammatory Bowel Diseases, Moscow Clinical Research and Practical Center, and to determine the predictors of a therapy respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e535de6842239a4ac7435d56b20293
https://ter-arkhiv.ru/0040-3660/article/viewFile/32155/pdf
https://ter-arkhiv.ru/0040-3660/article/viewFile/32155/pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Knyazev OV; А.S. Loginov Moscow Clinical Research Center, Moscow Healthcare Department, Moscow, Russia., Kagramanova AV; А.S. Loginov Moscow Clinical Research Center, Moscow Healthcare Department, Moscow, Russia., Lishchinskaya AA; А.S. Loginov Moscow Clinical Research Center, Moscow Healthcare Department, Moscow, Russia., Samsonova NG; А.S. Loginov Moscow Clinical Research Center, Moscow Healthcare Department, Moscow, Russia., Orlova NV; А.S. Loginov Moscow Clinical Research Center, Moscow Healthcare Department, Moscow, Russia., Rogozina VA; А.S. Loginov Moscow Clinical Research Center, Moscow Healthcare Department, Moscow, Russia., Parfenov AI; А.S. Loginov Moscow Clinical Research Center, Moscow Healthcare Department, Moscow, Russia.
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2018 Jun 20; Vol. 90 (6), pp. 74-80.